The DOI matches its Crossref record; 97 of the 98 references it cites were found in a registry or an index.
TGFβ1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice
Open accessAbstract
TGFbeta1 has been implicated in cell cycle control and carcinogenesis. To address the exact function of TGFbeta1 in skin carcinogenesis in vivo, mice with TGFbeta1 expression targeted to keratinocytes were subjected to long-term chemical carcinogenesis treatment. TGFbeta1 showed biphasic action during multistage skin carcinogenesis, acting early as a tumor suppressor but later enhancing the malignant phenotype. The transgenics were more resistant to induction of benign skin tumors than controls, but the malignant conversion rate was vastly increased. There was also a higher incidence of spindle cell carcinomas, which expressed high levels of endogenous TGFbeta3, suggesting that TGFbeta1 elicits an epithelial-mesenchymal transition in vivo and that TGFbeta3 might be involved in maintenance of the spindle cell phenotype. The action of TGFbeta1 in enhancing malignant progression may mimic its proposed function in modulating epithelial cell plasticity during embryonic development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, TGF-β3 is clearly expressed by stromal CAFs and mesenchymal tumor cells41,70,247”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [41]
Citations
Cites
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U., Liotta, L. A., Falanga, V., & Kehrl, J. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4167 · Cited by 2,867
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S. D., Wang, J., Myeroff, L. L., Parsons, R. E., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,267
Kaartinen, V., Voncken, J. W., Shuler, C. F., Warburton, D., Bu, D., Heisterkamp, N., & Groffen, J. (1995) · Nature Genetics · doi:10.1038/ng1295-415 · Cited by 1,042
Miettinen, P. J., Ebner, R., Lopez, A. R., & Derynck, R. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.127.6.2021 · Cited by 939
Transforming growth factor–β3 is required for secondary palate fusion
Proetzel, G., Pawlowski, S. A., Wiles, M. V., Yin, M., Boivin, G. P., Howles, P. N., Ding, J., Ferguson, M. W. J., & Doetschman, T. (1995) · Nature Genetics · doi:10.1038/ng1295-409 · Cited by 908
Derynck, R., Goeddel, D. V., Ullrich, A., Gutterman, J. U., Williams, R. D., Bringman, T. S., & Berger, W. H. (1987) · PubMed · Cited by 898
Kimelman, D., & Kirschner, M. W. (1987) · Cell · doi:10.1016/0092-8674(87)90110-3 · Cited by 872
The Transforming Growth Factor-βs
Roberts, A. B., & Sporn, M. B. (1991) · Springer eBooks · doi:10.1007/978-1-4612-3210-0_8 · Cited by 869
The Transforming Growth Factor-βs
Roberts, A. B., & Sporn, M. B. (1990) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-49295-2_8 · Cited by 744
Ansari, B., Coates, P. J., Greenstein, B., & Hall, P. A. (1993) · The Journal of Pathology · doi:10.1002/path.1711700102 · Cited by 578
Research works printed but not linked: 11
- Arteaga, 1990, Growth stimulation of human breast cancer cells with anti-transforming growth factor β antibodies, Cell Growth Differ., 1, 367
- Caulin, 1995, Chronic exposure of cultured transfected mouse epidermal cells to TGFβ1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype, Cell Growth Differ., 6, 1027
- Cui, W., and Akhurst, R.J. (1996). Transforming growth factors β: biochemistry and biology in vitro and in vivo. In Growth Factors and Cytokines in Health and Disease, C. Bondy and D. LeRoith, eds. (Greenwich, Connecticut: JAI Press), in press.
- Cui, 1994, Lack of TGFβ1 expression in benign skin tumours of p53 null mice is prognostic for a high risk of malignant conversion, Cancer Res., 54, 5831
- Dlugosz, 1995, Autocrine transforming growth factor α is dispensible for v-ras-Ha-induced epidermal neoplasia, Cancer Res., 55, 1883
- Fowlis, 1992, Discordant TGFβ1 RNA and protein localisations during chemical carcinogenesis of the skin, Cell Growth Differ., 3, 81
- Fowlis, 1996, Altered epidermal growth control in vivo in transgenic mice expressing TGFβ1 from an inducible keratin gene promoter, Cell Growth Differ., 7, 679
- Gomella, 1989, Expression of transforming growth factor α in normal adult kidney and enhanced expression of transforming growth factors α and β in renal cell carcinoma, Cancer Res., 49, 6972
- Manning, 1991, Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β (TGF-β), Oncogene, 6, 1471
- Steiner, 1992, Transforming growth factor-β-1 overproduction in prostate cancer, Mol. Endocrinol., 6, 15
- Tennenbaum, 1992, Extracellular matrix receptors and mouse skin carcinogenesis, Cancer Res., 52, 2966
Cited by
Sorted by citations
Items 401–500 of 623
Bone Morphogenetic Protein 7 Inhibits Tumor Growth of Human Uveal Melanoma In Vivo
Notting, I. C., Buijs, J. T., Mintardjo, R., van der Horst, G., Vukičević, S., Löwik, C. W. G. M., Schalij-Delfos, N. E., KEUNEN, J. E. E., & van der Pluijm, G. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0505 · Cited by 21
DeCensi, A., Torrisi, R., Fontana, V., Barreca, A., Ponzani, P., Pensa, F., Parodi, S., & Costa, A. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10170-8 · Cited by 21
Cannon, R. E., Spalding, J. W., Trempus, C. S., Szczesniak, C. J., Virgil, K. M., Humble, M. C., & Tennant, R. W. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199709)20:1 · Cited by 50
Liu, S., Iaria, J., Simpson, R. J., & Zhu, H. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0223-4 · Cited by 20
Wilkins-Port, C. E., Higgins, S. P., Higgins, C. E., Kobori-Hotchkiss, I., & Higgins, P. J. (2012) · Biochemistry Research International · doi:10.1155/2012/454368 · Cited by 20
Notch Intracellular Domain Expression in Various Skin Fibroproliferative Diseases
Kim, J., Lee, J. H., Jeong, K. H., Kim, G. M., & Kang, H. (2014) · Annals of Dermatology · doi:10.5021/ad.2014.26.3.332 · Cited by 20
TGF 1 polymorphism (L10P) and risk of colorectal adenomatous and hyperplastic polyps
Sparks, R. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh102 · Cited by 20
Transforming growth factor‐β1 ‐509T reduces risk of colorectal cancer, but not adenoma in Koreans
Chung, S. J., Kim, J. S., Jung, H. C., & Song, I. S. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00401.x · Cited by 19
Bhayal, A. C., Prabhakar, B., Rao, K. P. R., Penchikala, A., Qamar, A., Jyothy, A., Nallari, P., & Venkateshwari, A. (2011) · Tumor Biology · doi:10.1007/s13277-011-0208-z · Cited by 19
Harnessing Carcinoma Cell Plasticity Mediated by TGF-β Signaling
Wang, X., & Thiery, J. P. (2021) · Cancers · doi:10.3390/cancers13143397 · Cited by 18
Qian, Y., Wang, R., Wei, W., Wang, M., & Wang, S. (2021) · Human & Experimental Toxicology · doi:10.1177/09603271211041678 · Cited by 19
Rodrigues‐Junior, D. M., Tan, S. S., Lim, S. K., Leong, H. S., Melendez, M. E., Ramos, C. R. N., Viana, L. D. S., Tan, D. S.-W., Carvalho, A. L., Iyer, N. G., et al. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz148 · Cited by 19
Cytoplasmic PML: From Molecular Regulation to Biological Functions
Jin, G., Gao, Y., & Lin, H. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24727 · Cited by 19
Lindemann, R. K., Nordheim, A., & Dittmer, J. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-20 · Cited by 18
Ramakrishna, V., Negri, D. R. M., Brusić, V., Fontanelli, R., Canevari, S., Bolis, G., Castelli, C., & Parmiani, G. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970926)73:1 · Cited by 26
Proteins involved in cutaneous basal cell carcinoma development
Ciążyńska, M. A., Bednarski, I. A., Wódz, K., Kolano, P., Narbutt, J., Sobjanek, M., Woźniacka, A. J., & Lesiak, A. (2018) · Oncology Letters · doi:10.3892/ol.2018.9126 · Cited by 18
Shams, K., Larypoor, M., & Salimian, J. (2021) · Medical Oncology · doi:10.1007/s12032-021-01591-x · Cited by 18
Melanoma and Nonmelanoma Skin Cancers and the Immune System
Domingo, D. S., & Baron, E. D. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-77574-6_15 · Cited by 19
The immunopharmacological properties of transforming growth factor beta
Le, Y., Yu, X., Ruan, L., Wang, O., Qi, D., Zhu, J., Lu, X., Kong, Y., Cai, K., Pang, S., et al. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.07.006 · Cited by 18
Transforming growth factor β1 enhances tumor promotion in mouse skin carcinogenesis
Pérez‐Lorenzo, R., Markell, L. M., Hogan, K. A., Yuspa, S. H., & Glick, A. B. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq041 · Cited by 18
Liver stem cells and molecular signaling pathways in hepatocellular carcinoma.
Kitisin, K., Pishvaian, M. J., Johnson, L. B., & Mishra, L. (2007) · PubMed Central · Cited by 18
Bayat, Z., Ahmadi‐Motamayel, F., Parsa, M. S., & Taherkhani, A. (2021) · Genomics & Informatics · doi:10.5808/gi.21052 · Cited by 18
The Complexities of TGF-β Action During Mammary and Squamous Cell Carcinogenesis
Connolly, E. C., & Akhurst, R. J. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111798808284 · Cited by 20
Self-citationOwens, D. M., Broad, S., Yan, X., Benitah, S. A., & Watt, F. M. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20118 · Cited by 17
Li, Y. R., Kandyba, E. E., Halliwill, K. D., Delrosario, R., Tran, Q., Bayani, N., Wu, D., Mirzoeva, O. K., Reeves, M. Q., Islam, S. M. A., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-1379 · Cited by 16
Self-citationEngineering cancer resistance in mice
Klatt, P. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg057 · Cited by 16
Kim, J., Yu, S. J., Park, B., Cheong, H. S., Pasaje, C. F. A., Bae, J. S., Lee, H., Shin, H. D., & Kim, Y. J. (2011) · Digestive Diseases · doi:10.1159/000327559 · Cited by 15
Xu, D., Yuan, R., Gu, H., Liu, T., Tu, Y., Yang, Z. H., & Li, H. (2013) · Archives of Dermatological Research · doi:10.1007/s00403-013-1361-6 · Cited by 15
Harradine, K. A., Ridd, K., Saunier, E. F., Clermont, F. F., Pérez‐Losada, J., Moore, D. H., Epstein, E. H., Bastian, B. C., & Akhurst, R. J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3286 · Cited by 15
Self-citationXu, X. L., & Kapoun, A. M. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-12 · Cited by 14
Tsutsumi, S., Tomisato, W., Hoshino, T., Tsuchiya, T., & Mizushima, T. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222700606 · Cited by 14
Ito, D., Fujimoto, K., Doi, R., Koizumi, M., Toyoda, E., Mori, T., Kami, K., Kawaguchi, Y., Whitehead, R. H., & Imamura, M. (2004) · Surgery · doi:10.1016/j.surg.2004.05.012 · Cited by 14
Transforming Growth Factor beta (TGFβ)
Serra, R. A. (2002) · Encyclopedia of Life Sciences · doi:10.1038/npg.els.0000934 · Cited by 14
Ganapathy, A., Paterson, I. C., Prime, S. S., Eveson, J. W., Pring, M., Price, N., Threadgold, S. P., & Davies, M. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.06.008 · Cited by 13
TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosis
Loos, B., Salas-Bastos, A., Nordin, A., Debbache, J., Stierli, S., Cheng, P. F., Rufli, S., Wyss, C., Levesque, M. P., Dummer, R., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07305-1 · Cited by 13
Cioni, C., Tassi, M., Marotta, G., Mugnaini, C., Corelli, F., & Annunziata, P. (2019) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524919666190923154351 · Cited by 13
Anti-angiogenic activity of para-coumaric acid methyl ester on HUVECs in vitro and zebrafish in vivo
Zhang, H.-Z., Li, C.-Y., Wu, J., Wang, R., Wei, P., Liu, M.-H., & He, M. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.04.056 · Cited by 13
TGF-beta antiproliferative effects in tumor suppression
Law, B. K. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s297 · Cited by 13
Pancreatic carcinoma cell lines with SMAD4 inactivation show distinct expression responses to TGFB1
Jonson, T., Heidenblad, M., Håkansson, P., Gorunova, L., Johansson, B., Fioretos, T., & Höglund, M. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10179 · Cited by 13
Kang, K., Sun, W. T., Nomata, K., Morita, I., Cruz, A., Liu, C., Trosko, J. E., & Chang, C. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199804)21:4 · Cited by 43
Han, C. L., Demetris, A. J., Liu, Y., Shelhamer, J. H., & Wu, T. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.a115.404852 · Cited by 13
RetractedChemical Enhancers of Cytokine Signaling that Suppress Microfilament Turnover and Tumor Cell Growth
Park, H.-J., Partridge, E. A., Cheung, P., Pawling, J., Donovan, R., Wrana, J. L., & Dennis, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2542 · Cited by 12
Higashi, T., Kyo, S., Inoue, M., Tanii, H., & Saijoh, K. (2006) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.050133 · Cited by 12
Desmoplasia in Different Degrees of Invasion of Carcinoma Ex-Pleomorphic Adenoma
de Araújo, V. C., Furuse, C., Cury, P. R., ALTEMANI, A. M. D. A. M., Alves, V. A. F., & de Araújo, N. S. (2007) · Head and Neck Pathology · doi:10.1007/s12105-007-0028-z · Cited by 12
17beta-Estradiol Is a Hormonal Regulator of Mirex Tumor Promotion Sensitivity in Mice
Porter, K. L. (2002) · Toxicological Sciences · doi:10.1093/toxsci/69.1.42 · Cited by 12
GDF11 as a friend or an enemy in the cancer biology?
Król, W., Machelak, W., & Zielińska, M. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188944 · Cited by 12
Riemenschneider, M. J., Hirblinger, M., Vollmann‐Zwerenz, A., Hau, P., Proescholdt, M. A., Jaschinski, F., Rothhammer-Hampl, T., Wosikowski, K., Janicot, M., & Leo, E. (2015) · Oncotarget · doi:10.18632/oncotarget.5780 · Cited by 11
Rose, A., Spender, L. C., Stephen, C., Mitchell, A., Rickaby, W., Bray, S. E., Evans, A. T., Dayal, J., Purdie, K. J., Harwood, C. A., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24545 · Cited by 11
Cheng, M.-L., Chen, H., Tsai, J.-P., Lee, Y.-P., Shih, Y.-C., Chang, C.-M., & Ting, C. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0805474 · Cited by 11
Effect of Transforming Growth Factor-beta (TGF-β) on Mammary Development
Plaut, K. I., Dean, A. J., Patnode, T. A., & Casey, T. (2003) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(03)74036-3 · Cited by 11
Transforming Growth Factor Beta and Breast Cancer
Kaklamani, V., & Pasche, B. (2005) · Cancer treatment and research · doi:10.1007/0-387-24361-5_6 · Cited by 11
Qi, P., Ruan, C., Wang, H., Zhou, F. ‐., Zhao, Y. ‐., Gu, X., & Gao, C. (2009) · Colorectal Disease · doi:10.1111/j.1463-1318.2009.02079.x · Cited by 10
Inhibition of TGF-β signaling, invasion, and growth of cutaneous squamous cell carcinoma by PLX8394
Siljamäki, E., Riihilä, P., Suwal, U., Nissinen, L. M., Rappu, P., Kallajoki, M. A., Kähäri, V., & Heino, J. (2023) · Oncogene · doi:10.1038/s41388-023-02863-8 · Cited by 10
Cao, S., Liu, S., Wang, F., Liu, J., Li, M., Wang, C., & Xi, S. (2015) · Mediators of Inflammation · doi:10.1155/2015/790652 · Cited by 10
PAI-1: A Multifunctional SERPIN with Complex Roles in Cell Signaling and Migration
Wilkins-Port, C. E., Freytag, J., Higgins, S. P., & Higgins, P. J. (2010) · Cell Communication Insights · doi:10.4137/cci.s5260 · Cited by 10
Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin
Lepley, D. M., & Pelling, J. C. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199707)19:2 · Cited by 164
Chabeli, M. S., Wang, X., Liang, Y., Chen, C., Yang, C., Shou, Y., Wang, S., & Chen, K. (2022) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2022.100621 · Cited by 9
Deciphering TGF-β1's role in drug resistance and leveraging plant bioactives for cancer therapy
Deb, V. K., Chauhan, N., & Jain, U. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177218 · Cited by 10
Jin, H., Xie, X., Hu, B., Gao, F., Zhou, J., Zhang, Y., Du, L., Wang, X., Zhao, L., Zhang, X., et al. (2012) · Oncology Reports · doi:10.3892/or.2012.2128 · Cited by 9
Park, D. Y. (2003) · Hepatology Research · doi:10.1016/s1386-6346(03)00264-x · Cited by 9
TGF-β Signaling Alterations in Cancer
Bian, Y., Kaklamani, V., Reich, J., & Pasche, B. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-48158-8_3 · Cited by 9
Davies, M., Paterson, I. C., Stone, A. M., Huntley, S., Patel, V., Curtis, R., Matthews, J. B., Pring, M., Eveson, J. W., & Prime, S. S. (1999) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1999.tb02110.x · Cited by 9
Cellular and Molecular Mechanisms of Tumor Promotion
Rundhaug, J. E., & Fischer, S. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01416-0 · Cited by 12
Kitisin, K., Shetty, K., Mishra, L., & Johnson, L. B. (2007) · Cancer Biomarkers · doi:10.3233/cbm-2007-34-509 · Cited by 10
Warusavitarne, J. H., McDougall, F. K., Silva, K. D., Barnetson, R. A., Messina, M., Robinson, B. G., & Schnitzler, M. (2008) · International Journal of Colorectal Disease · doi:10.1007/s00384-008-0606-x · Cited by 8
Ferguson-Smith, M. A., & Goudie, D. R. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.04.007 · Cited by 8
Caderni, G., Perrelli, M.-G., Cecchini, F., & Tessitore, L. (2002) · Carcinogenesis · doi:10.1093/carcin/23.2.323 · Cited by 8
Yeudall, W. A., Jakus, J., Ensley, J. F., & Robbins, K. C. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199702)18:2 · Cited by 45
Special issue: TGF-β and epithelial-mesenchymal transition in cancer
ten Dijke, P., Miyazono, K., Heldin, C., & Moustakas, A. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.06.002 · Cited by 7
Ali, M. M., Itoh, Y., Badji, A. M. P., Gallant, S., Tsirigoti, C., Bai, Y., Filipek‐Górniok, B., Miyazawa, K., Heldin, C., & Moustakas, A. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08435-4 · Cited by 7
Markell, L. M., Masiuk, K. E., Blazanin, N., & Glick, A. B. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0112 · Cited by 7
Roy, C. L., Maisnier-Patin, K., Leduque, P., Li, J. Y., Saez, J. M., & Langlois, D. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00176-8 · Cited by 7
New Experimental Models of Skin Homeostasis and Diseases
Larcher, F., Espada, J., Díaz-Ley, B., Jaén, P., Juarranz, Á., & Quintanilla, M. (2014) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2014.11.013 · Cited by 6
T-Cell Type Acute Lymphoblastic Leukemia Following Cyclosporin A Therapy for Aplastic Anemia
Hirose, Y., Masaki, Y., Ebata, K., Okada, J., Kim, C. G., Ogawa, N., Wano, Y., & Sugai, S. (2001) · International Journal of Hematology · doi:10.1007/bf02981942 · Cited by 7
Smad2 suppresses the growth of Mv1Lu cells subcutaneously inoculated in mice
Sjöblom, T., Yakymovych, I., Heldin, C. H., Östman, A., & Souchelnytskyi, S. (2003) · European Journal of Cancer · doi:10.1016/j.ejca.2003.08.016 · Cited by 7
Dicker, T., Serewko-Auret, M. M., Russell, T., Dahler, A. L., Saunders, N. A., Rothnagel, J. A., & Strutton, G. M. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01739.x · Cited by 7
Blagosklonny, M. V., & Darżynkiewicz, Z. (2006) · Springer eBooks · doi:10.1007/0-387-23695-3_17 · Cited by 6
Albumin Acts Like Transforming Growth Factor β1 in Microbubble-Based Drug Delivery
Chuang, Y.-H., Wang, Y.-H., Chang, T.-K., Lin, C., & Li, P. (2014) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2013.10.022 · Cited by 6
Role of Transforming Growth Factor β in Human Disease
(2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430322 · Cited by 6
Wosiak, A., Szmajda‐Krygier, D., Pietrzak, J., Boncela, J., & Balcerczak, E. I. (2023) · Bioengineering · doi:10.3390/bioengineering10050570 · Cited by 6
Takayashiki, N., Kawata, H., Kamiakito, T., & Tanaka, A. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.01.031 · Cited by 6
Berger, D. H., O'Mahony, C. A., Sheng, H., Shao, J., Albo, D., DuBois, R. N., & Beauchamp, R. D. (2003) · Surgery · doi:10.1067/msy.2003.125 · Cited by 6
Park, D. Y., Hwang, S. Y., & Suh, K. S. (2001) · Toxicologic Pathology · doi:10.1080/019262301317226348 · Cited by 6
Kim, Y. J., & Lee, H.-S. (2009) · The Korean Journal of Hepatology · doi:10.3350/kjhep.2009.15.1.7 · Cited by 6
Inhibition of the TGF-β Signaling Pathway in Tumor Cells
Podar, K., Raje, N. S., & Anderson, K. C. (2007) · Springer eBooks · doi:10.1007/978-3-540-31209-3_6 · Cited by 5
Tumour promotion through the lens of evolution
López-Bigas, N., Kandyba, E. E., González-Pérez, A., Brennan, P., & Balmain, A. (2026) · Nature · doi:10.1038/s41586-026-10386-x · Cited by 8
Self-citationHe, F., Chen, X., Zhu, Y., Pang, H., Li, Z., Liang, P., Jin, T., Chen, Z., Chen, Z., Hu, J., et al. (2025) · MedComm · doi:10.1002/mco2.70148 · Cited by 5
Nuevos modelos experimentales para el estudio de la homeostasis y la enfermedad cutánea
Larcher, F., Espada, J., Díaz-Ley, B., Jaén, P., Juarranz, Á., & Quintanilla, M. (2014) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2014.03.008 · Cited by 5
Santibanez, J. F., Quintanilla, M., & Martı́nez, J. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02760-6 · Cited by 5
The Molecular Basis of Skin Carcinogenesis
Missero, C., D’Errico, M., Dotto, G. P., & Dogliotti, E. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-125-1_18 · Cited by 5
Heiserman, J. P., & Akhurst, R. J. (2025) · Cells · doi:10.3390/cells14191518 · Cited by 4
Self-citationFAM96A suppresses epithelial–mesenchymal transition and tumor metastasis by inhibiting TGFβ1 signals
Zhao, N., He, M., Chen, W., Jin, P., Cao, L., Deng, J., Xu, C., & Wang, L. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120607 · Cited by 4
Low dose TGF-β1 can improve vohwinkel syndrome by promoting the proliferation of keratinocytes
Ling, X., Dong, S., & Zhang, L. (2023) · Acta Histochemica · doi:10.1016/j.acthis.2023.152010 · Cited by 4
Jung, M., Lin, T., & Sonia, B. (2012) · InTech eBooks · doi:10.5772/25948 · Cited by 4
Li, F., & Zhou, M. (2013) · Developmental Dynamics · doi:10.1002/dvdy.23933 · Cited by 4
Chang, H.-M., Lin, Y.-Y., Tsai, P.-C., Liang, C.-T., & Yan, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105299 · Cited by 4
A suppressor role for soluble endoglin in cancer
Quintanilla, M., Castillo, G. D., Sánchez-Blanco, E., Martín-Villar, E., Valbuena-Díez, A. C., Langa, C., Pérez-Gómez, E., Renart, J., & Bernabéu, C. (2015) · Cancer Cell & Microenvironment · doi:10.14800/ccm.706 · Cited by 4
Organization of Cells into Higher-Ordered Structures
Ahlstrom, J. D., & Erickson, C. A. (2007) · Elsevier eBooks · doi:10.1016/b978-012370615-7/50010-x · Cited by 4
Seike, M., Ikeda, M., Nakajima, H., & Kodama, H. (2005) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2005.tb00850.x · Cited by 4
Metadata
- Authors
- Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A., & Akhurst, R. J.
- Affiliations
- University of Glasgow (GB)
- Corresponding author
- Akhurst, Rosemary J
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1996-08
- Volume
- 86
- Issue
- 4
- Pages
- 531-542
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2026460094
- Cited by
- 628
- References
- 98
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 10 · 2023: 20 · 2022: 6 · 2021: 6 · 2020: 7 · 2019: 8 · 2018: 13 · 2017: 12 · 2016: 9 · 2015: 15 · 2014: 22 · 2013: 22 · 2012: 26
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- TGF-β1, skin carcinogenesis, sarcomatoid carcinoma, keratinocytes, tumor suppressor, malignant progression, TGF-beta3, epithelial-mesenchymal transition, chemical carcinogenesis, transgenic mice, epithelial cell plasticity
- MeSH terms
- Animals, Carcinoma, Carcinoma, Squamous Cell, Cells, Cultured, Female, Immunologic Techniques, Keratins, Mice, Transgenic, Papilloma, Skin Neoplasms, Integrins, Transforming Growth Factor beta, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review